Molecular Definition of Breast Tumor Heterogeneity
Michail Shipitsin(C4 Therapeutics (United States)), Kornélia Polyák(Dana-Farber Cancer Institute), Stuart J. Schnitt(Brigham and Women's Hospital), Noga Bloushtain-Qimron(Dana-Farber Cancer Institute), Jun Yao(The University of Texas MD Anderson Cancer Center), Marc K. Halushka(University of Baltimore), Andrea L. Richardson(Johns Hopkins University), Lauren L. Campbell(Harvard University), Lyndsay N. Harris(National Institutes of Health), Stanislawa Weremowicz(Brigham and Women's Hospital), Rameen Beroukhim(Broad Institute), Karen S. Anderson(Arizona State University), Rebecca Gelman(Dana-Farber Cancer Institute), Yuri Nikolsky(Johns Hopkins University), Saraswati Sukumar(Johns Hopkins University), Min Hu(Harvard University), Leroy M. Parker(Harvard University), Tatiana Nikolskaya(Russian Academy of Sciences), Tatiana Serebryiskaya(Vavilov Institute of General Genetics), Pedram Argani(Johns Hopkins University), Judy E. Garber(Dana-Farber Cancer Institute)
Cited by 1,353
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k